Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...
GLP-1 agents "have an intricate web of various effects," Al-Aly said in a press briefing. For example, the analysis showed ...
The myocardial infarction market is driven by the growing prevalence of cardiovascular diseases and advancements in diagnostics and treatments. Key factors include an aging population, ...
Announcing a new article publication for Cardiovascular Innovations and Applications journal. This study sought to determine the potential of extracellular vesicle (EV) microRNAs (miRNAs) to serve as ...
The association between hospital-diagnosed migraine and increased risks to cardiovascular health cannot be attributed to NSAID use.
Wearable devices can reduce cardiovascular events and death in ischemic heart disease, according to a new meta-analysis, but ...